Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy (Nature, (2022), 606, 7915, (797-803), 10.1038/s41586-022-04833-8)

Christopher P. Vellano; Michael G. White; Miles C. Andrews; Manoj Chelvanambi; Russell G. Witt; Joseph R. Daniele; Mark Titus; Jennifer L. McQuade; Fabio Conforti; Elizabeth M. Burton; Matthew J. Lastrapes; Gabriel Ologun; Alexandria P. Cogdill; Golnaz Morad; Peter Prieto; Alexander J. Lazar; Yanshuo Chu; Guangchun Han; M. A.Wadud Khan; Beth Helmink; Michael A. Davies; Rodabe N. Amaria; Jeffrey J. Kovacs; Scott E. Woodman; Sapna Patel; Patrick Hwu; Michael Peoples; Jeffrey E. Lee; Zachary A. Cooper; Haifeng Zhu; Guang Gao; Hiya Banerjee; Mike Lau; Jeffrey E. Gershenwald; Anthony Lucci; Emily Z. Keung; Merrick I. Ross; Laura Pala; Eleonora Pagan; Rossana Lazcano Segura; Qian Liu; Mikayla S. Borthwick; Eric Lau; Melinda S. Yates; Shannon N. Westin; Khalida Wani; Michael T. Tetzlaff; Lauren E. Haydu; Mikhila Mahendra; Xiao Yan Ma; Christopher Logothetis; Zachary Kulstad; Sarah Johnson; Courtney W. Hudgens; Ningping Feng; Lorenzo Federico; Georgina V. Long; P. Andrew Futreal; Swathi Arur; Hussein A. Tawbi; Amy E. Moran; Linghua Wang; Timothy P. Heffernan; Joseph R. Marszalek; Jennifer A. Wargo

doi:10.1038/s41586-022-05632-x

Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy (Nature, (2022), 606, 7915, (797-803), 10.1038/s41586-022-04833-8)

Christopher P. Vellano
, Michael G. White
, Miles C. Andrews
, Manoj Chelvanambi
, Russell G. Witt
, Joseph R. Daniele
, Mark Titus
, Jennifer L. McQuade
, Fabio Conforti
, Elizabeth M. Burton
, Matthew J. Lastrapes
, Gabriel Ologun
, Alexandria P. Cogdill
, Golnaz Morad
, Peter Prieto
, Alexander J. Lazar
, Yanshuo Chu
, Guangchun Han
, M. A.Wadud Khan
, Beth Helmink

Michael A. Davies, Rodabe N. Amaria, Jeffrey J. Kovacs, Scott E. Woodman, Sapna Patel, Patrick Hwu, Michael Peoples, Jeffrey E. Lee, Zachary A. Cooper, Haifeng Zhu, Guang Gao, Hiya Banerjee, Mike Lau, Jeffrey E. Gershenwald, Anthony Lucci, Emily Z. Keung, Merrick I. Ross, Laura Pala, Eleonora Pagan, Rossana Lazcano Segura, Qian Liu, Mikayla S. Borthwick, Eric Lau, Melinda S. Yates, Shannon N. Westin, Khalida Wani, Michael T. Tetzlaff, Lauren E. Haydu, Mikhila Mahendra, Xiao Yan Ma, Christopher Logothetis, Zachary Kulstad, Sarah Johnson, Courtney W. Hudgens, Ningping Feng, Lorenzo Federico, Georgina V. Long, P. Andrew Futreal, Swathi Arur, Hussein A. Tawbi, Amy E. Moran, Linghua Wang, Timothy P. Heffernan^*, Joseph R. Marszalek^*, Jennifer A. Wargo^*

^*Corresponding author for this work

University of Texas MD Anderson Cancer Center
Monash University
IRCCS Istituto Europeo di Oncologia - Milano
Guthrie Courtland Medical Center
Immunai Inc.
University of Rochester
Washington University St. Louis
Moffitt Cancer Center
AstraZeneca Pharmaceuticals LP
Novartis Pharmaceuticals Corporation
Novartis
University of Milan - Bicocca
University of California at San Francisco
The University of Sydney
Oregon Health and Science University

Research output: Contribution to journal › Comment/debate

Abstract

In the version of this article initially published, author affiliation 5, now reading “Division of Melanoma, Sarcoma, and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy,” incorrectly included “Medical Oncology for” in the name of the division, and the IRCCS was not included. The errors have been corrected in the HTML and PDF versions of the article.

Original language	English
Pages (from-to)	E3
Journal	Nature
Volume	613
Issue number	7945
DOIs	https://doi.org/10.1038/s41586-022-05632-x
State	Published - 26 Jan 2023
Externally published	Yes

Access to Document

10.1038/s41586-022-05632-x

Cite this

Vellano, C. P., White, M. G., Andrews, M. C., Chelvanambi, M., Witt, R. G., Daniele, J. R., Titus, M., McQuade, J. L., Conforti, F., Burton, E. M., Lastrapes, M. J., Ologun, G., Cogdill, A. P., Morad, G., Prieto, P., Lazar, A. J., Chu, Y., Han, G., Khan, M. A. W., ... Wargo, J. A. (2023). Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy (Nature, (2022), 606, 7915, (797-803), 10.1038/s41586-022-04833-8). Nature, 613(7945), E3. https://doi.org/10.1038/s41586-022-05632-x

@article{1b20061e09a243e9a9b66b9d60ef1772,

title = "Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy (Nature, (2022), 606, 7915, (797-803), 10.1038/s41586-022-04833-8)",

abstract = "In the version of this article initially published, author affiliation 5, now reading “Division of Melanoma, Sarcoma, and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy,” incorrectly included “Medical Oncology for” in the name of the division, and the IRCCS was not included. The errors have been corrected in the HTML and PDF versions of the article.",

author = "Vellano, \{Christopher P.\} and White, \{Michael G.\} and Andrews, \{Miles C.\} and Manoj Chelvanambi and Witt, \{Russell G.\} and Daniele, \{Joseph R.\} and Mark Titus and McQuade, \{Jennifer L.\} and Fabio Conforti and Burton, \{Elizabeth M.\} and Lastrapes, \{Matthew J.\} and Gabriel Ologun and Cogdill, \{Alexandria P.\} and Golnaz Morad and Peter Prieto and Lazar, \{Alexander J.\} and Yanshuo Chu and Guangchun Han and Khan, \{M. A.Wadud\} and Beth Helmink and Davies, \{Michael A.\} and Amaria, \{Rodabe N.\} and Kovacs, \{Jeffrey J.\} and Woodman, \{Scott E.\} and Sapna Patel and Patrick Hwu and Michael Peoples and Lee, \{Jeffrey E.\} and Cooper, \{Zachary A.\} and Haifeng Zhu and Guang Gao and Hiya Banerjee and Mike Lau and Gershenwald, \{Jeffrey E.\} and Anthony Lucci and Keung, \{Emily Z.\} and Ross, \{Merrick I.\} and Laura Pala and Eleonora Pagan and Segura, \{Rossana Lazcano\} and Qian Liu and Borthwick, \{Mikayla S.\} and Eric Lau and Yates, \{Melinda S.\} and Westin, \{Shannon N.\} and Khalida Wani and Tetzlaff, \{Michael T.\} and Haydu, \{Lauren E.\} and Mikhila Mahendra and Ma, \{Xiao Yan\} and Christopher Logothetis and Zachary Kulstad and Sarah Johnson and Hudgens, \{Courtney W.\} and Ningping Feng and Lorenzo Federico and Long, \{Georgina V.\} and Futreal, \{P. Andrew\} and Swathi Arur and Tawbi, \{Hussein A.\} and Moran, \{Amy E.\} and Linghua Wang and Heffernan, \{Timothy P.\} and Marszalek, \{Joseph R.\} and Wargo, \{Jennifer A.\}",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s), under exclusive licence to Springer Nature Limited.",

year = "2023",

month = jan,

day = "26",

doi = "10.1038/s41586-022-05632-x",

language = "英语",

volume = "613",

pages = "E3",

journal = "Nature",

issn = "0028-0836",

publisher = "Nature Research",

number = "7945",

}

Vellano, CP, White, MG, Andrews, MC, Chelvanambi, M, Witt, RG, Daniele, JR, Titus, M, McQuade, JL, Conforti, F, Burton, EM, Lastrapes, MJ, Ologun, G, Cogdill, AP, Morad, G, Prieto, P, Lazar, AJ, Chu, Y, Han, G, Khan, MAW, Helmink, B, Davies, MA, Amaria, RN, Kovacs, JJ, Woodman, SE, Patel, S, Hwu, P, Peoples, M, Lee, JE, Cooper, ZA, Zhu, H, Gao, G, Banerjee, H, Lau, M, Gershenwald, JE, Lucci, A, Keung, EZ, Ross, MI, Pala, L, Pagan, E, Segura, RL, Liu, Q, Borthwick, MS, Lau, E, Yates, MS, Westin, SN, Wani, K, Tetzlaff, MT, Haydu, LE, Mahendra, M, Ma, XY, Logothetis, C, Kulstad, Z, Johnson, S, Hudgens, CW, Feng, N, Federico, L, Long, GV, Futreal, PA, Arur, S, Tawbi, HA, Moran, AE, Wang, L, Heffernan, TP, Marszalek, JR & Wargo, JA 2023, 'Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy (Nature, (2022), 606, 7915, (797-803), 10.1038/s41586-022-04833-8)', Nature, vol. 613, no. 7945, pp. E3. https://doi.org/10.1038/s41586-022-05632-x

TY - JOUR

T1 - Author Correction

T2 - Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy (Nature, (2022), 606, 7915, (797-803), 10.1038/s41586-022-04833-8)

AU - Vellano, Christopher P.

AU - White, Michael G.

AU - Andrews, Miles C.

AU - Chelvanambi, Manoj

AU - Witt, Russell G.

AU - Daniele, Joseph R.

AU - Titus, Mark

AU - McQuade, Jennifer L.

AU - Conforti, Fabio

AU - Burton, Elizabeth M.

AU - Lastrapes, Matthew J.

AU - Ologun, Gabriel

AU - Cogdill, Alexandria P.

AU - Morad, Golnaz

AU - Prieto, Peter

AU - Lazar, Alexander J.

AU - Chu, Yanshuo

AU - Han, Guangchun

AU - Khan, M. A.Wadud

AU - Helmink, Beth

AU - Davies, Michael A.

AU - Amaria, Rodabe N.

AU - Kovacs, Jeffrey J.

AU - Woodman, Scott E.

AU - Patel, Sapna

AU - Hwu, Patrick

AU - Peoples, Michael

AU - Lee, Jeffrey E.

AU - Cooper, Zachary A.

AU - Zhu, Haifeng

AU - Gao, Guang

AU - Banerjee, Hiya

AU - Lau, Mike

AU - Gershenwald, Jeffrey E.

AU - Lucci, Anthony

AU - Keung, Emily Z.

AU - Ross, Merrick I.

AU - Pala, Laura

AU - Pagan, Eleonora

AU - Segura, Rossana Lazcano

AU - Liu, Qian

AU - Borthwick, Mikayla S.

AU - Lau, Eric

AU - Yates, Melinda S.

AU - Westin, Shannon N.

AU - Wani, Khalida

AU - Tetzlaff, Michael T.

AU - Haydu, Lauren E.

AU - Mahendra, Mikhila

AU - Ma, Xiao Yan

AU - Logothetis, Christopher

AU - Kulstad, Zachary

AU - Johnson, Sarah

AU - Hudgens, Courtney W.

AU - Feng, Ningping

AU - Federico, Lorenzo

AU - Long, Georgina V.

AU - Futreal, P. Andrew

AU - Arur, Swathi

AU - Tawbi, Hussein A.

AU - Moran, Amy E.

AU - Wang, Linghua

AU - Heffernan, Timothy P.

AU - Marszalek, Joseph R.

AU - Wargo, Jennifer A.

PY - 2023/1/26

Y1 - 2023/1/26

N2 - In the version of this article initially published, author affiliation 5, now reading “Division of Melanoma, Sarcoma, and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy,” incorrectly included “Medical Oncology for” in the name of the division, and the IRCCS was not included. The errors have been corrected in the HTML and PDF versions of the article.

AB - In the version of this article initially published, author affiliation 5, now reading “Division of Melanoma, Sarcoma, and Rare Tumors, European Institute of Oncology, IRCCS, Milan, Italy,” incorrectly included “Medical Oncology for” in the name of the division, and the IRCCS was not included. The errors have been corrected in the HTML and PDF versions of the article.

UR - https://www.scopus.com/pages/publications/85145995268

U2 - 10.1038/s41586-022-05632-x

DO - 10.1038/s41586-022-05632-x

M3 - 评论/辩论

C2 - 36627494

AN - SCOPUS:85145995268

SN - 0028-0836

VL - 613

SP - E3

JO - Nature

JF - Nature

IS - 7945

ER -

Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy (Nature, (2022), 606, 7915, (797-803), 10.1038/s41586-022-04833-8)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this